Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers - Contacts and Locations

Home

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

This study has been completed.

Study NCT00002752. Last updated on November 22, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002752

Locations


United States, North Carolina
	Duke Comprehensive Cancer Center
	Durham, North Carolina, United States, 27710

Sponsors and Collaborators

Duke University

Investigators


Study Chair:	Darell D. Bigner, MD, PhD	Duke University